October 06, 2026
Quick answer: LDM, short for local dynamic micro-massage, is an ultrasound technology developed by the German company Wellcomet. Instead of holding one frequency, the handpiece switches very rapidly between two megahertz frequencies (for example 3 and 10 MHz), and newer triple-frequency versions between three (1/3/10 or 3/10/19 MHz). The rationale is that rapidly changing frequencies give the skin's cells a stronger stress-signalling stimulus than one steady frequency. The clinical studies are small, mostly retrospective and largely co-written by the manufacturer's own scientist, so LDM is a gentle, plausible technology with early evidence, not an established treatment.
Ultrasound is a pressure wave above the range of hearing. At megahertz frequencies the tissue under the handpiece is compressed and relaxed millions of times a second over microscopic distances; that is the "micro-massage". It is not massage in the everyday sense, and nothing moves that you could see or feel as pressure. The higher the frequency, the more of the energy is absorbed close to the surface, which is why facial devices work in the megahertz range rather than at the lower frequencies used on deep muscle.
The case for alternating frequencies comes from cell work. When cultured human leukaemia cells were exposed to 1, 3 and 10 MHz ultrasound and combinations of two, the heat shock protein Hsp72, one of the cell's own protective stress proteins, rose with frequency to about 1,800% of baseline at 10 MHz, while 1 MHz produced no significant rise. The effect depended on warmth: with the water bath at 30 °C nothing was induced, and the authors suggested that heat and ultrasound act together (Sontag 2009). Wellcomet's scientific department has since proposed that thermo-mechanical stress from very-high-frequency or multi-frequency ultrasound raises caveolin-1, a membrane protein involved in cell signalling, and that this might help protect skin during radiation therapy (Kruglikov 2025). Both are mechanistic proposals built on cells in a dish and on theory. Neither shows what happens in a living face during a 30-minute session.
Alternating frequencies does not change the physics of product delivery. Megahertz ultrasound raises skin permeability only modestly and briefly; the dramatic delivery figures in trade material come from low-frequency laboratory equipment. LDM is not a way to drive a serum into the dermis, and a session that feels like nothing is the expected experience, not a sign that it failed.
"Dual-frequency ultrasound" is a category, not one machine. One facial study of 26 people with rosacea or acne treated weekly for four weeks used a different dual-frequency device at 1 and 3 MHz in an impulse mode, five minutes per cheek. TEWL fell from 28.91 to 18.82 g/h/m² and the erythema index by 8.6% at six weeks, with no control group (Kim 2021). A retrospective review of 42 people with treatment-resistant rosacea also reported lower erythema and TEWL after dual-frequency ultrasound, but its abstract does not name the device (Park 2018). These results support ultrasound for redness in general. They cannot simply be credited to LDM.
The LDM-specific papers are encouraging and thin. In 22 people with acne treated with triple-frequency LDM, nine dermatologists blinded to the treatment rated photographs and found the acne score improved by 73.7% at the last session and 90.1% at follow-up (Chervinskaya 2025). After nose surgery, 24 people given daily LDM for five days had swelling for 1.9 days and bruising for 2.8 days, against 4.5 and 7.4 days in 24 people given ice packs (Ahn 2024). Both abstracts describe retrospective designs, there was no sham device, and both list a Wellcomet scientist as co-author. That does not make the findings wrong. It does mean they have not yet been tested by independent, controlled trials.
Any ultrasound session needs intact skin, no active infection, no acute flare and no heat still settling from a recent energy treatment. It is not used over an implanted electronic device, a known thrombosis or the thyroid, and pregnancy needs specific clearance. The device manual outranks any general list. A skin that is already inflamed or stinging is not ready for a stimulus of any kind, gentle or not; telling rosacea redness apart from a damaged barrier matters before any device is chosen.
The technique decides more than the label on the handpiece: a generous water-based layer that never dries, full contact without pressure, constant movement, a fixed number of passes per zone and a low starting output. More stimulation is not more repair, as the case against chasing stronger treatments explains.
Do not use LDM in place of medical treatment for acne or rosacea, stack it with an exfoliating step at the same visit, or ask for the output to be raised because you could not feel anything. It is also not a substitute for the deliberate tissue injury behind collagen remodelling; how a facial differs from an advanced treatment explains why that line matters.
Painful nodules, acne that is leaving scars, rosacea that involves the eyes, or redness that spreads, burns or swells need a physician or dermatologist; diagnosis and prescription belong there. After any ultrasound session, blistering, swelling, persistent pain, signs of infection, or a reaction that is worsening rather than settling after 48 hours should be seen by a doctor promptly.
The evidence so far is a handful of small studies, most retrospective, none with a sham device, measured over weeks rather than years, and much of it written with the manufacturer. The mechanism rests on cultured cells and hypothesis papers. The clearest independent signal, lower redness and water loss in rosacea and acne, comes from dual-frequency devices in general rather than from LDM in particular. That is enough to call LDM reasonable and low-risk when well run, and not enough to promise a specific result. Read this as education about a device category: it is not a diagnosis, and it is not a substitute for an assessment by a physician or dermatologist.
Literature retrieved from PubMed.
A brand name tells you who made the handpiece. It does not tell you whether your skin is ready, which solution should sit under it, or what output is right for a first session. At the COMPLETE ELIXIR Skin Lab, ultrasound is planned around your skin's tolerance and your current routine rather than a device label. Book the complimentary 45-minute consultation and bring the products you use now, so the plan starts from what your skin is actually doing.
For recovery after professional treatments, visit the Post-Treatment Skin Recovery Resource Centre.
Written and reviewed by Clara Song, Ph.D.
Founder and in-house formulator, COMPLETE ELIXIR
Ph.D. in Data Science · Medical Aesthetician Diploma
Last reviewed: October 6, 2026
This article distinguishes ingredient evidence, formulation rationale, finished-product evidence and professional observation. It is educational and does not replace medical diagnosis or treatment.
October 07, 2026
October 07, 2026
October 07, 2026
